Skip to main navigation
Oyster Point Pharma Oyster Point Pharma Oyster Point Pharma Oyster Point Pharma

Investor Relations

  • Who We Are
    • Board of Directors
    • Leadership Team
  • Our Focus
  • Pipeline
    • OC-01
  • Investors & News
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Investor Requests
      • Email Alerts
  • Careers
  • Contact
Oyster Point Pharma Oyster Point Pharma

Investor Relations

  • Who We Are
    • Board of Directors
    • Leadership Team
  • Our Focus
  • Pipeline
    • OC-01
  • Investors & News
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Investor Requests
      • Email Alerts
  • Careers
  • Contact

Breadcrumb

  1. Home
  2. Investors
  3. Node

Oyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare Conference

  • Read more about Oyster Point Pharma to Attend the Piper Sandler 32nd Annual Virtual Healthcare Conference

Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual Meeting

  • Read more about Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at the American Academy of Ophthalmology 2020 Virtual Annual Meeting

Oyster Point Pharma Reports Third Quarter 2020 Financial Results and Recent Business Highlights

  • Read more about Oyster Point Pharma Reports Third Quarter 2020 Financial Results and Recent Business Highlights

Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020

  • Read more about Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020

Michael G. Atieh

  • Chair of the Audit Committee
Michael G. Atieh
Financial Expert

Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of Growth

  • Read more about Oyster Point Pharma Announces Board of Directors Leadership Changes and New Appointment as the Company Advances into Next Phase of Growth

Oyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

  • Read more about Oyster Point Pharma to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights

  • Read more about Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights

Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020

  • Read more about Oyster Point Pharma to Report Second Quarter 2020 Financial Results on August 5, 2020

Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  • Read more about Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »
Subscribe to

Shareholder Tool

Print Page
Email Alerts
Information Requests
logo

Investor Relations

  • Who We Are
  • Our Focus
  • Pipeline
  • Investors & News
  • Careers
  • Contact

Footer Menu Two

  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Sitemap

Oyster Point Pharma, Inc
202 Carnegie Center, Suite 109
Princeton, New Jersey 08540
United States

General Inquiries
(609) 382-9032
info@oysterpointrx.com

Media Contact
media@oysterpointrx.com

© 2021 Oyster Point Pharma, Inc. Oyster Point™ and the Oyster Point logo are trademarks of Oyster Point Pharma, Inc.

Social Menu

We use cookies to deliver our online services. Details of the cookies can be found by clicking the 'Cookie settings' link. To agree to our use of cookies click 'Accept.'. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. The cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. The cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always Enabled

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.